Puerto Rico Cannabis Industry by the Numbers (2026)

## The Short Version Puerto Rico is a medical-only jurisdiction. Licensed cannabis requires a valid medical patient registration with the JRCM. The program has been running for a decade, and as of 2026 it is a mature medical market by most measures, with dispensary density comparable to mainstream US medical states, a patient population in the tens of thousands, and an annual sales figure that puts it in the same rough bracket as Rhode Island or Vermont. This piece is a data snapshot. Where the numbers are firm (licensed operator counts published by the Junta Reglamentadora de Cannabis Medicinal), they are cited as firm. Where they are estimates (market-size figures, patient-visit counts, price points), they are flagged as estimates. The intent is to give adults 21+ with a valid patient registration, plus operators and industry observers, a defensible read on what the Puerto Rico market looks like in 2026. ## Dispensary Count The operational figure: **around 100 licensed dispensaries** are serving patients across Puerto Rico as of early 2026. The JRCM publishes the licensed-operator list through its official channels; the count has hovered in the 90-120 range for the last several years, with some churn at the margins as operators enter and exit. Distribution skews heavily toward the San Juan metro. A rough geographic breakdown of dispensary locations: - **San Juan metro (Old San Juan, Condado, Santurce, Miramar, Isla Verde, Carolina, Bayamón, Guaynabo):** roughly 40-50 shops, the clear gravity center - **East coast (Fajardo, Luquillo, Rio Grande, Humacao):** 8-12 shops serving the El Yunque + off-island corridor - **West coast (Rincón, Aguadilla, Isabela, Mayagüez):** 10-15 shops across the surf-town and university belt - **South coast (Ponce, Cabo Rojo, Guanica):** 8-10 shops - **Central mountains (Caguas, Cayey, Adjuntas):** 6-10 shops - **Off-islands (Vieques, Culebra):** near-zero licensed retail. Patients typically shop on the main island before ferry crossings. This distribution matters for visitor planning: a tourist anchored in San Juan has dozens of options within a 20-minute cab ride. A tourist staying in a west-coast surf town or a south-coast beach town has fewer, and the shops that do operate in smaller markets tend to have shorter hours. ## Dispensary Density vs US States Per-capita density is a reasonable comparison metric. Puerto Rico has a population of roughly 3.2 million. At 100 licensed dispensaries, that's **one shop per ~32,000 residents**. For comparison (rough figures, all approximate): - **Oklahoma:** one shop per ~1,500 residents (the highest density in the US, an outlier) - **Montana:** one shop per ~4,000 residents - **Colorado:** one shop per ~6,000 residents - **Oregon:** one shop per ~6,500 residents - **Maine:** one shop per ~3,500 residents - **Massachusetts:** one shop per ~15,000 residents - **Florida:** one shop per ~25,000 residents (medical-only, like PR) - **New York:** one shop per ~45,000 residents (still scaling, as of 2026) Puerto Rico sits in the same bracket as Florida. Both are medical-only programs, both are at roughly one shop per 25,000-35,000 residents. That's a mature medical-market density, well above a pre-launch or early-launch state and below the high-churn adult-use markets. ## Patient Enrollment The population of active registered patients in the Puerto Rico program is **estimated at 50,000+ as of 2026**. This is an estimate; the JRCM has periodically published patient-count figures, and the active population has been in the 40,000-60,000 range across the last several years with a gradual upward trend. Key splits to understand: - **Resident long-term patients** make up the large majority of the active-registration base. These are PR residents with qualifying conditions who renew annually. - **Visiting tourist patients** (temporary registrations) add to the total but are a small minority by headcount, though they contribute disproportionately to revenue per transaction. - **Minor patients** are a small fraction, operating under stricter oversight. This site's editorial posture treats the program as open to adults 21+; minor-patient mechanics are outside the scope of a tourist guide. Patient growth peaked during the **2018-2023 launch-and-expansion window**, when the program went from a few thousand pilot patients to a five-digit active base. Growth has flattened somewhat since 2023 as the initial addressable population has normalized, with net additions now running closer to a steady-state replacement cadence. ## Market Size Annual legal cannabis sales in Puerto Rico are **estimated at roughly $150 million in 2026**. This is an estimate; industry analyst reports in this range have been published, and the figure aligns with the observable dispensary count, patient base, and per-transaction norms. The comparison set: - Rhode Island legal cannabis sales (medical + nascent adult-use): ~$100-150M annually - Vermont legal cannabis sales (medical + adult-use): ~$150-200M annually - New Mexico (medical + adult-use): ~$500M+ annually - Florida (medical-only, comparable framing to PR): ~$2B annually (population ~7x PR) On a per-capita basis, PR's roughly $47 per resident per year puts the market below mature adult-use states (Colorado at ~$400 per resident, Oregon at ~$300) and below Florida (~$280 per resident). That is consistent with a medical-only program serving a subset of the population rather than a broad adult-use market. ## The Growth Curve, 2018-2023 The Puerto Rico program had two distinct growth phases: ### Phase 1 — 2015 to 2018: the pilot years The 2015 executive order established the program; the first dispensaries opened in 2017. Through 2018, the market was small, with a handful of operators, a few thousand patients, and significant regulatory uncertainty as the JRCM built out its operational framework. ### Phase 2 — 2018 to 2023: the expansion years This was the growth window. Dispensary counts tripled. Patient registrations climbed through the five-digit threshold. The tourist-registration path for visitors became a functioning operational reality by 2019-2020. Hurricane-season disruptions (Maria in 2017, subsequent storms) did not derail the growth curve materially. The COVID-19 era accelerated telehealth-based patient onboarding, including for visitors. ### Phase 3 — 2023 to 2026: maturation Growth has flattened. Dispensary counts have plateaued in the 90-120 range. Patient growth is running closer to replacement. Sales figures are stable year-over-year. The industry has transitioned from "scaling" to "operating." ## What the Data Doesn't Capture Some load-bearing realities that the numbers understate or miss entirely: - **Cash-heavy operations.** Federal banking restrictions mean most PR dispensaries are cash-preferred. Reported sales may modestly understate the full market given the friction in electronic-payment reconciliation. - **The illicit market.** Puerto Rico, like every jurisdiction with a legal medical program, has a persistent illicit market that predates the legal one. Rough analyst estimates put the illicit market at comparable scale to the legal one, though estimation here is difficult. - **Tourist patient revenue concentration.** Visiting patients are small by headcount but contribute disproportionately per visit. Typical visitor transactions run larger than resident-patient maintenance buys. For dispensaries in tourist-heavy districts (Condado, Old San Juan, Rincón), visitors may represent 15-30% of revenue despite being a single-digit percentage of the patient base. - **Product-mix shifts.** Flower remains the dominant category by unit volume. Edibles, vapes, and concentrates have gained share over the last five years. Topicals and tinctures are consistently small but steady. ## Regulatory Framework Snapshot The JRCM (Junta Reglamentadora de Cannabis Medicinal) is the program regulator and handles: - Cultivator licensing - Processor and manufacturer licensing - Dispensary licensing - Patient registration (resident and temporary/visitor) - Physician certification oversight - Product testing requirements Key compliance realities, as of 2026: - **No adult-use market.** All sales are patient-registered. - **No interstate commerce.** Federal law prohibits transporting cannabis across state or territorial lines, including on flights back to the mainland. - **No on-site consumption.** Dispensaries are retail-only; there is no licensed lounge category at the scale of states like Nevada or New Jersey. - **Testing standards.** JRCM-licensed product is laboratory-tested, and test results are available at the point of sale. ## What This Means for a Visiting Patient For an adult 21+ visitor with a valid patient registration in hand, the data translates roughly as follows: - **Selection is wide.** Roughly 100 licensed shops across the island. A San Juan-based trip puts dozens of options within a cab ride. - **Pricing is reasonable.** Per-gram and per-package pricing in 2026 runs comparable to mainstream US medical markets. Some importers price above mainland norms; most local operators price at or slightly below. - **Product quality is solid.** The regulated market has matured to the point where the typical licensed shop carries lab-tested flower, pre-rolls, edibles, vapes, tinctures, and topicals in a familiar product-category set. - **The paperwork is the gate.** The program's size and maturity do not change the core operational reality: the temporary patient registration is what unlocks all of the above. Without it, none of these 100 shops can sell to a visitor. ## Compliance - Puerto Rico is a medical-only jurisdiction. Licensed cannabis requires a valid medical patient registration with the JRCM. - 21+ with a valid patient registration. - No on-site consumption at any licensed dispensary. - No consumption in public spaces or on federally-managed land. - Federal law prohibits transporting cannabis across state or territorial lines, including on flights back to the mainland. - Start low, go slow for any product category, especially for first-time patients in a new market. ## Where to Go Next - [The tourist patient registration guide](/puerto-rico/medical-card-visitor-info/puerto-rico-medical-cannabis-tourist-guide) - [How Puerto Rico's program compares to US states](/puerto-rico/medical-card-visitor-info/puerto-rico-cannabis-program-compare-us-states) - [Medical vs street cannabis, and why legal matters](/puerto-rico/medical-card-visitor-info/medical-vs-street-cannabis-puerto-rico-why-legal-matters) **This is editorial, not legal advice. Figures cited as estimates are clearly marked.**